Circulation, Vol 87, 874-880, Copyright © 1993 by American Heart Association
AH Chester, SP Allen, S Tadjkarimi and MH Yacoub
BACKGROUND. Platelets release two powerful vasoconstrictors-- thromboxane
A2 (TXA2) and 5-hydroxytryptamine (5-HT). Animal studies have suggested
that these two substances may act in a synergistic fashion to stimulate
platelet activity and smooth muscle vasoconstriction. METHODS AND RESULTS.
To assess the interaction between TXA2 and 5-HT at the individual 5-HT
receptor subtypes reported to mediate contraction, the effect of the amine
was determined in the presence of differing concentrations of the
thromboxane mimetic U46619. A total of 168 vessel segments were removed
from 20 recipient hearts of patients undergoing cardiac transplantation.
Segments were set up in isolated organ baths and tested for their response
to 5-HT in the presence of an EC10, EC30, or EC50 concentration of U46619
(n = 4). A synergistic response was only seen in a small number of the
segments tested under these conditions. However, in the presence of
ketanserin (10(-6) M) to block 5-HT2 receptors, there was a significant
increase in the response to 10(-6) M 5-HT in the presence of both the EC30
(p < 0.025) and EC50 (p < 0.05) concentrations of U46619 (n = 4). The
potentiation of non-5-HT2 receptor mediated responses to 5-HT, in the
presence of U46619 (EC30), could be prevented by 10(-7) M methiothepin, a
nonselective 5-HT1-like/5-HT2 receptor antagonist. CONCLUSIONS. These data
indicate that TXA2 receptor activation can increase the response of 5-HT
mediated by 5-HT1-like receptors in human coronary arteries. 5- HT1-like
receptors have been shown to mediate the contractile effect of 5-HT in
patients with variant and chronic stable angina. Thus, platelet contents
may act together at specific receptor subtypes in the induction of
myocardial ischemia.
ARTICLES
Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries
National Heart and Lung Institute, Harefield Hospital, Middlesex, UK.
This article has been cited by other articles:
![]() |
K. Leineweber, D. Bose, M. Vogelsang, M. Haude, R. Erbel, and G. Heusch Intense Vasoconstriction in Response to Aspirate From Stented Saphenous Vein Aortocoronary Bypass Grafts J. Am. Coll. Cardiol., March 7, 2006; 47(5): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Kelsall, A. H. Chester, M. Amrani, and D. R.J. Singer C-Type Natriuretic Peptide Relaxes Human Coronary Artery Bypass Grafts Preconstricted by Endothelin-1 Ann. Thorac. Surg., October 1, 2005; 80(4): 1347 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Watts 5-Hydroxytryptamine-Induced Potentiation of Endothelin-1- and Norepinephrine-Induced Contraction Is Mitogen-Activated Protein Kinase Pathway Dependent Hypertension, January 1, 2000; 35(1): 244 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Reznik, Y. Rosen, and B. Rosen An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms J Psychopharmacol, March 1, 1999; 13(2): 193 - 195. [Abstract] [PDF] |
||||
![]() |
T. Ishida, K.-i. Hirata, T. Sakoda, S. Kawashima, H. Akita, and M. Yokoyama Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary arteries Cardiovasc Res, January 1, 1999; 41(1): 267 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MaassenVanDenBrink, M. Reekers, W. A. Bax, M. D. Ferrari, and P. R. Saxena Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs Circulation, July 7, 1998; 98(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-W. Fu and J. C Longhurst Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats J. Physiol., June 15, 1998; 509(3): 729 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kadokami, K. Egashira, K. Kuwata, Y. Fukumoto, T. Kozai, H. Yasutake, T. Kuga, H. Shimokawa, K. Sueishi, and A. Takeshita Altered Serotonin Receptor Subtypes Mediate Coronary Microvascular Hyperreactivityin Pigs With Chronic Inhibitionof Nitric Oxide Synthesis Circulation, July 15, 1996; 94(2): 182 - 189. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |